Today I came across a case with AML patient in the lab. Patient was dx with AML when admitted in mid 2010 and typed as A pos. Pt has been multiply transfused with irradiated O pos RBC (and non-type specific platelets) throughout the year. 2 months ago patient forward typing was changed to O while the reversed typing remains A (I understand that patient was volume replaced due to repeated transfusion with O pos cells). Just last week patient was re-admitted and both forward and reversed typing demonstrated O. Forward typing was AntiA-0, Anti B-0 at both Immediate Spin and 10 min RT incubation. Reverse typing was 1+s immediated spin, 2+s 10' incubation and 2+ at 37C, 10' incubation. Antibody screen was negative with Liss AHG 10'. I also did a "mini cold panel" using patient serum O cord cell, O adult cells, A1 adult cells, A2 adult cells and auto control, at IS, 10'RT and 10' 4C. Everything turned up negative except A1 Adult cells. So I ruled out non specific cold agglutinins and cold auto antibodies. I called the floor and asked whether patient had BM transplant at some point of his life and the answer was NO. I understand that Antigens can be weaken and forward typing can change in oncology patients. What I dont understand is if the patient is intrinsically capable of producing ABH antibody while his antigens are weaken. Or Am I typing some "junk" as Anti A1? ?